Michael Kranda, MBA

Chief Executive Officer

Michael previously served as SVP of Alliance Management at AskBio and guided their central nervous system (CNS) gene therapy portfolio. Prior to joining AskBio, Kranda served as Senior Director of Business Development for the Allen Institute where he led efforts to establish partnerships initiatives in gene and cell therapy, and 3D machine learning enabled cell imaging. Kranda previously served as one of original board members for the Allen Institute for Brain Science as well as Managing Director of Vulcan Capital, Microsoft co-founder Paul Allen’s life science venture capital group. Prior positions in the industry include President of Immunex, CEO of Oxford GlycoSciences, and Director and Audit Committee Chairman for PTC Therapeutics. Michael holds BA and MBA degrees in finance from the University of Washington.